MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland · Delayed Price · Currency is CHF 0.2300
+0.0145 (6.73%)
Jun 22, 2026, 5:31 PM CET
SWX:MMTX Revenue
In the year 2025, MindMaze Therapeutics Holding had annual revenue of 642.00K CHF.
Revenue
642.00K
Revenue Growth
n/a
P/S Ratio
54.67
Revenue / Employee
64.20K
Employees
10
Market Cap
35.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 642.00K | - | - |
| Dec 31, 2024 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMindMaze Therapeutics Holding News
- 6 months ago - Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics - Accesswire
- 7 months ago - Relief Therapeutics Shareholders Approve Business Combination with NeuroX - Accesswire
- 8 months ago - Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 - Accesswire
- 11 months ago - Relief Therapeutics Publishes 2025 Half-Year Report - Accesswire
- 11 months ago - Relief Therapeutics Advances Publication of 2025 Half-Year Report - Accesswire
- 11 months ago - Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze - Accesswire
- 1 year ago - Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 - Accesswire
- 1 year ago - Relief Therapeutics Announces Results of Annual General Meeting - Accesswire